Skip to main content

Table 3 Comparison of TAG double bond number concentrations in NAFLD cases and healthy controls

From: Serum lipids are associated with nonalcoholic fatty liver disease: a pilot case-control study in Mexico

# of double bonds

P-value

Model 1a

Model 2b

Model 3c

Model 4d

Model 5e

Model 6f

0

< 0.1

< 0.01

0.06

< 0.01

< 0.01

0.04

1

< 0.1

< 0.01

0.15

< 0.01

< 0.01

0.12

2

0.05

0.06

0.69

0.06

0.07

0.71

3

0.20

0.28

0.86

0.16

0.24

0.71

4

0.32

0.48

0.83

0.19

0.32

0.62

5

0.26

0.39

0.94

0.12

0.21

0.83

6

0.14

0.21

0.63

0.05

0.09

0.81

7

0.08

0.13

0.42

0.03

0.05

0.55

8

0.10

0.14

0.38

0.04

0.07

0.50

9

0.26

0.36

0.71

0.15

0.22

0.85

10

0.10

0.16

0.37

0.05

0.10

0.53

11

0.45

0.55

0.37

0.49

0.61

0.45

12

0.97

0.90

0.83

0.70

0.83

0.77

  1. a Adjusted for age and sex
  2. b Adjusted for age, sex, and PNPLA3 genotype
  3. c Adjusted for age, sex, diabetes, and metabolic syndrome status
  4. d Adjusted for age, sex, and BMI category
  5. e Adjusted for age, sex, PNPLA3 genotype and BMI category
  6. f Adjusted for age, sex, diabetes, metabolic syndrome status, and PNPLA3 genotype Abbreviations: NAFLD nonalcoholic fatty liver disease, TAG triacylglycerol